LQDA Bathi mangsa ngarep Liquidia Corp

Simbol resmi perusahaan Liquidia Corp (LQDA)

Liquidia Corporation (LQDA) management is demonstrating resilience in patent disputes regarding the launch of its flagship product. An analytical assessment of future profits reflects market expectations, where the metric level stands at 0.35. However, litigation is constraining revenue, although the development of various dosages of inhaled pulmonary medications minimizes commercial threats, establishing a foundation for future growth.

liquidia.com (LQDA): Bathi resik sing dikarepake saka 13.08.2025 nganti 18.11.2026

Liquidia Technologies - rincian analitis lan metrik utama (LQDA)

- rega saham lan konsensus proyeksi valuasi:
Analisis fundamental perusahaan:LQDA, Liquidia
Produk dadi Liquidia Corp

This indicator assesses the business's ability to generate future cash flow by neutralizing seasonal risks and cost volatility through the analysis of recurring quarterly cycles. For Liquidia Corporation (LQDA), this metric reflects the monetization of the PRINT platform, where unique dosing creates barriers to entry for competitors, as clearly evidenced by the trend in expected marginal profit.

Analisis pesaing Liquidia Corporation

Bathi mangsa ngarep HLN|Proyeksi bathi mangsa ngarep Kenvue Corp|Bathi mangsa ngarep VRNA (Verona Pharma Corp)|MENS (Jyong Bio) - Penghasilan resik sing dikarepake|Bathi sing dikarepake Ligand Pharmaceuticals Incorporated LGND|Amneal (AMRX) - Bathi resik sing dikarepake|PRGO: Bathi mangsa ngarep|Alvotech SA - Bathi resik mangsa ngarep|GLPG: Proyeksi bathi mangsa ngarep|ANI Pharma - Penghasilan resik sing dikarepake|MNKD (MannKind Corp) - Proyeksi bathi mangsa ngarep|Bathi resik sing dikarepake amphastar.com AMPH|Bathi sing dikarepake Pacira BioSciences, Inc. (PCRX)|SPRY (ARS Pharmaceuticals, Inc.) - Penghasilan resik sing dikarepake|Theravance Biopharma, Inc. - Bathi mangsa ngarep|Proyeksi bathi mangsa ngarep Aquestive Corp AQST|scPharmaceuticals - Proyeksi bathi mangsa ngarep|Bathi resik sing dikarepake tectonictx.com|Tonix Pharmaceuticals Inc. (TNXP) - Bathi sing dikarepake|SXTC - Prakiraan bathi perusahaan|Bathi sing dikarepake eupraxiapharma.com|BHST: Penghasilan resik sing dikarepake|Bathi mangsa ngarep EXOZ (Invizyne Technologies)|ORMP - Bathi resik sing dikarepake|Proyeksi bathi mangsa ngarep ENTX (Entera Bio Ltd)|Proyeksi bathi mangsa ngarep MindWalk Holdings, Inc. HYFT|ABVC BioPharma, Inc - Proyeksi bathi mangsa ngarep|CPIX: Bathi sing dikarepake|QNTM (Quantum BioPharma Ltd) - Bathi mangsa ngarep|Prakiraan bathi resik FGEN|Bathi sing dikarepake Telomir Pharmaceuticals|RANI: Penghasilan resik sing dikarepake|Proyeksi bathi mangsa ngarep SNYR|Bathi mangsa ngarep Rallybio Corp RLYB|Bathi sing dikarepake Lexaria Bioscience Corp. LEXX|Prakiraan bathi perusahaan pulmatrix.com (PULM)|Pheton Holdings Limited - Proyeksi bathi mangsa ngarep|Bathi forward APM|LYRA (Lyra Therapeutics Inc.) - Bathi mangsa ngarep|IBO - Prakiraan bathi perusahaan|Bathi mangsa ngarep TNFA|Prakiraan bathi resik YCBD (cbdmd.com)|Bathi mangsa ngarep PRFX (PainReform Ltd)|CYTO: Bathi forward|Proyeksi bathi mangsa ngarep LIPO (lipella.com)|Bathi resik mangsa ngarep OPTN (OptiNose Corp)|PIRS: Bathi mangsa ngarep|PROC - Proyeksi bathi mangsa ngarep|PTPI: Proyeksi bathi mangsa ngarep|Qilian International Holding Group (QLI) - Proyeksi bathi mangsa ngarep|SLRN (ACELYRIN, Inc.) - Proyeksi bathi mangsa ngarep|TFF Pharmaceuticals (TFFP) - Prakiraan bathi perusahaan